Quarterly report pursuant to Section 13 or 15(d)

Financial instruments (Details Narrative)

v3.20.2
Financial instruments (Details Narrative) - USD ($)
Aug. 04, 2020
May 29, 2020
May 15, 2020
Sep. 30, 2020
Cash, insured amount       $ 800,000
Accounts payable and accrued liabilities       2,400,000
Notes payable current portion       500,000
Proceeds from shares issued $ 4,680,000   $ 4,680,000  
Credit Concentration Risk [Member]        
Cash, uninsured amount       $ 13,800,000
Maximum [Member]        
Sale of offerings as common stocks     $ 100,000,000  
Maximum [Member] | At Market Issuance Sales Agreement [Member]        
Proceeds from shares issued   $ 10,000,000